Abbott Laboratories (ABT) Enterprise Value (2009 - 2026)

Abbott Laboratories has disclosed Enterprise Value across 18 years of filings, most recently posting -$6.7 billion for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$6.7 billion, down 0.97% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.7 billion (down 0.97% YoY), and the FY2025 annual result was -$8.3 billion, down 7.35% from the prior year.
• Enterprise Value came in at -$6.7 billion for Q1 2026 at Abbott Laboratories, up from -$8.3 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$6.4 billion in Q1 2024 to a low of -$10.0 billion in Q4 2022.
• The 5-year median for Enterprise Value is -$7.6 billion (2024), against an average of -$7.8 billion.
• Across the five-year window, Enterprise Value decreased 17.43% in 2023 and soared 31.06% in 2024, its largest moves.
• Abbott Laboratories' Enterprise Value stood at -$10.0 billion in 2022, then rose by 29.1% to -$7.1 billion in 2023, then declined by 9.57% to -$7.7 billion in 2024, then retreated by 7.35% to -$8.3 billion in 2025, then advanced by 19.8% to -$6.7 billion in 2026.
• The last three Enterprise Value figures came in at -$6.7 billion (Q1 2026), -$8.3 billion (Q4 2025), and -$7.4 billion (Q3 2025), per Business Quant data.